腹水评估

Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 1998;27:264-272.

• 摘要

Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004;350:578-585.

• 摘要

1.  Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55:vi1-vi12.

• 摘要

2.  Krige JEJ, Beckingham IJ. Clinical review: ABC of disease of liver, pancreas and biliary system. Portal hypertension-2. Ascites, encephalopathy and other conditions. BMJ. 2001;322:416-418.

• 全文
• 摘要

3.  Ginès P, Cardenas A., Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004;350:1646-1654.

• 摘要

4.  Sikuler E, Ackerman Z, Braun M, et al. Guidelines for diagnosis and management of cirrhotic ascites and its complications. The Israeli Association for the Study of the Liver [in Hebrew]. Harefuah. 2012;151:705-708;719.

• 摘要

5.  Royal College of Obstetricians and Gynaecologists. Management of ascites in ovarian cancer patients. November 2014. https://www.rcog.org.uk/ (last accessed 28 July 2016).

• 全文

6.  Ricart E, Soriano G, Novella MT, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol. 2000;32:596-602.

• 摘要

7.  Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985;5:457-462.

• 摘要

8.  Chen TA, Lo GH, Lai KH, et al. Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics. World J Gastroenterol. 2005;11:6823-6827.

• 摘要

9.  Angeli P, Guarda S, Fasolato S, et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther. 2006;23:75-84.

• 摘要

10.  Strauss E, Caly WR. Spontaneous bacterial peritonitis: a therapeutic update. Expert Rev Anti Infect Ther. 2006;4:249-260.

• 摘要

11.  Runyon BA. Management of adult patients with ascites due to cirrhosis. Hepatology. 1998;27:264-272.

• 摘要

12.  Akriviadis EA. Hemoperitoneum in patients with ascites. Am J Gastroenterol. 1997;92:567-575.

• 摘要

13.  Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215-220.

• 摘要

14.  Cattau E, Benjamin SB, Knuff TE, et al. The accuracy of the physical exam in the diagnosis of suspected ascites. JAMA. 1982;247:1164-1166.

• 摘要

15.  Light, RW. Clinical practice. Pleural effusion. N Engl J Med. 2002;346:1971-1977.

• 摘要

16.  Inadomi J, Cello JP, Koch J. Ultrasonographic determination of ascitic fluid. Hepatology. 1996;24:549-551.

• 摘要

17.  Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003 Jul;38(1):258-66.

• 摘要

18.  Krige JE, Beckingham IJ. Clinical review: ABC diseases of liver, pancreas and biliary system. Portal hypertension - 1: varices. BMJ. 2001;322:348-351.

• 全文
• 摘要

19.  Sakai H, Sheer TA, Mendler MH, et al. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005;25:984-986.

• 摘要

20.  McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164-171.

• 摘要

21.  Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55(suppl 6):vi1-vi12.

22.  European Association for the Study of the Liver. Clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.

23.  Kuiper JJ, van Buuren HR, de Man RA. Ascites in cirrhosis: a review of management and complications. Neth J Med. 2007;65(8):283-288.

24.  Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32(1):142-153.

25.  Bernardi M, Carceni P, Navickis RJ, et al. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology. 2012;55(4):1172-1181.

• 摘要

26.  Walsh K, Alexander G. Alcoholic liver disease. Postgrad Med J. 2000;76:280-286.

• 摘要

27.  Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137-e161.

• 摘要

28.  Davies MK, Gibbs CR, Lip GYH. Clinical review: ABC of heart failure. BMJ. 2000;320:297-300.

• 全文
• 摘要

29.  Orth SR. Ritz E. The nephrotic syndrome. N Engl J Med. 1998 Apr 23;338(17):1202-11.

• 摘要

30.  Aggarwal R, Ranjan P. Clinical review: Preventing and treating hepatitis B infection. BMJ. 2004;329:1080-1086.

• 全文
• 摘要

31.  Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261-1273.

• 摘要

32.  Ryder SD, Beckingham IJ. ABC of diseases of liver pancreas and biliary system. Other causes of parenchymal liver disease. BMJ. 2001;322:290-292.

• 全文
• 摘要

33.  Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med. 2004;350:2383-2397.

• 摘要

34.  Nishimura RA. Constrictive pericarditis in the modern era: a diagnostic dilemma. Heart. 2001;86:619-623.

• 摘要

35.  Osterberg L, Vagelos R, Atwood JE. Case presentation and review: constrictive pericarditis. West J Med. 1988;169:232-239.

• 摘要

36.  Oren RM, Grover-McKay M, Stanford W, et al. Accurate preoperative diagnosis of pericardial constriction using cine computed tomography. J Am Coll Cardiol. 1993;22:832-838.

• 摘要

37.  Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004;350:578-585.

• 摘要

38.  Wood ML, Foulds IS, French MA. Protein losing enteropathy due to systemic lupus erythematosus. Gut. 1984;25:1013-1015.

• 摘要

39.  Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;2:3.

• 摘要

40.  Turlakow A, Yeung HW, Salmon AS, et al. Peritoneal carcinomatosis: role of 18F-FDG PET. J Nucl Med. 2003;44:1407-1412.

• 摘要

41.  Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346:1212-1220.

• 摘要

42.  Mills JA. Systemic lupus erythematosus. N Engl J Med. 1994;330:1871-1879.

• 摘要

43.  Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003;96:623-633.

• 摘要

44.  Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg. 1996;224:10-18.

• 摘要

45.  al Karawi MA, Mohamed AE, Yasawy MI, et al. Protean manifestation of gastrointestinal tuberculosis: Report on 130 patients. J Clin Gastroenterol. 1995;20:225-232.

• 摘要

46.  Rompianesi G, Hann A, Komolafe O, et al. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis. Cochrane Database Syst Rev. 2017;(4):CD012010.

• 摘要

47.  Ravdin IS, Morrison ME, Smyth CM. Bile peritonitis and bile ascites. Ann Surg. 1929;89:867-877.

• 摘要